Lido Advisors LLC raised its position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 91.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,907 shares of the company’s stock after acquiring an additional 5,206 shares during the quarter. Lido Advisors LLC’s holdings in HCA Healthcare were worth $4,655,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. MidFirst Bank acquired a new position in HCA Healthcare in the 2nd quarter valued at $28,000. Clearstead Trust LLC acquired a new stake in HCA Healthcare during the 2nd quarter worth $29,000. Latitude Advisors LLC purchased a new stake in shares of HCA Healthcare during the third quarter worth $32,000. Delos Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare in the second quarter valued at about $35,000. Finally, Laurel Wealth Advisors LLC purchased a new position in shares of HCA Healthcare in the third quarter worth about $40,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.
HCA Healthcare Trading Down 0.0%
Shares of HCA opened at $498.82 on Monday. The company’s 50-day moving average price is $452.79 and its 200 day moving average price is $445.91. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52. The firm has a market cap of $104.20 billion, a P/E ratio of 16.53, a price-to-earnings-growth ratio of 1.67 and a beta of 1.11.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share for the quarter, topping the consensus estimate of $6.65 by $0.57. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The company had revenue of $19.85 billion during the quarter, compared to analyst estimates of $19.33 billion. During the same quarter last year, the firm posted $6.96 earnings per share. HCA Healthcare’s revenue was up 3.6% compared to the same quarter last year. Equities research analysts forecast that HCA Healthcare, Inc. will post 30.14 earnings per share for the current year.
HCA Healthcare Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, December 15th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.34%.
Analysts Set New Price Targets
A number of research firms recently weighed in on HCA. Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $381.00 to $468.00 and gave the stock an “equal weight” rating in a research report on Monday, November 2nd. Truist Financial reissued a “buy” rating and issued a $510.00 target price (up from $495.00) on shares of HCA Healthcare in a research note on Tuesday, November 3rd. Mizuho set a $495.00 price objective on HCA Healthcare in a research note on Wednesday, October 28th. Morgan Stanley dropped their target price on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a report on Monday, July 27th. Finally, Oppenheimer reduced their price target on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a report on Monday, July 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $480.13.
Read Our Latest Report on HCA Healthcare
Recent HCA Healthcare Headlines
Here are a few of the latest headlines about HCA:
- Neutral Sentiment: Zacks Research’s estimate changes were mixed: its FY2026 EPS forecast rose to $30.00, but it cut FY2027 to $30.87 and FY2028 to $33.98. The revisions offer a less uniformly strong forward earnings signal. HCA Healthcare analyst estimate updates
- Negative Sentiment: A senior vice president reportedly sold about $1.77 million in HCA shares. Insider sales can weigh on sentiment, although a sale alone does not establish a negative outlook. Insider selling at HCA Healthcare
- Negative Sentiment: Pomerantz LLP announced an investigation into claims on behalf of HCA investors. The announcement does not establish wrongdoing, but the added legal uncertainty could concern investors. Pomerantz investigation announcement
Insider Activity at HCA Healthcare
In other news, COO Jon M. Foster sold 21,713 shares of HCA Healthcare stock in a transaction on Friday, November 6th. The stock was sold at an average price of $494.95, for a total value of $10,746,849.35. Following the completion of the sale, the chief operating officer directly owned 10,000 shares of the company’s stock, valued at approximately $4,949,500. The trade was a 68.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Erica Rossitto sold 3,500 shares of the business’s stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $505.81, for a total value of $1,770,335.00. Following the completion of the sale, the senior vice president owned 13,426 shares in the company, valued at $6,791,005.06. This represents a 20.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 36,413 shares of company stock worth $18,251,464. Insiders own 1.50% of the company’s stock.
About HCA Healthcare
HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.
Recommended Stories
- Five stocks we like better than HCA Healthcare
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
